These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3503102)

  • 1. Reduction of intraocular pressure by domperidone.
    Chiou GC
    J Ocul Pharmacol; 1986; 2(2):131-8. PubMed ID: 3503102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Feb; 3(2):307-14. PubMed ID: 6142811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by domperidone of the ocular hypotensive effect of pergolide.
    al-Sereiti MR; Quik RF; Hedges A; Turner P
    Eur J Clin Pharmacol; 1990; 38(5):461-3. PubMed ID: 2379530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.
    Chiou GC; Chen YJ
    J Ocul Pharmacol; 1992; 8(4):285-94. PubMed ID: 1484260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular actions of an octahydrobenzo[f]quinoline: Ha117.
    Potter DE; Ogidigben MJ; Heath AR
    Eur J Pharmacol; 1993 May; 236(1):61-8. PubMed ID: 8100528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys.
    Burke JA; Potter DE
    Curr Eye Res; 1986 Sep; 5(9):665-76. PubMed ID: 2876846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
    Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the ocular hypotensive action of ketanserin.
    Chang FW; Burke JA; Potter DE
    J Ocul Pharmacol; 1985; 1(2):137-47. PubMed ID: 3880071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic involvement in intraocular pressure in the rabbit eye.
    Chiou GC; Chiou FY
    Ophthalmic Res; 1983; 15(3):131-5. PubMed ID: 6634049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular hypotensive actions of serotonin antagonist-ketanserin analogs.
    Chiou GC; Li BH
    J Ocul Pharmacol; 1992; 8(1):11-21. PubMed ID: 1402292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure.
    Bucolo C; Campana G; Di Toro R; Cacciaguerra S; Spampinato S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1362-9. PubMed ID: 10336527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
    Sharif NA
    Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ocular hypotensive action of SK&F 86466 in the conscious rabbit.
    Matthews WD; Sulpizio A; Fowler PJ; DeMarinis R; Hieble JP; Bergamini MV
    Curr Eye Res; 1984 May; 3(5):737-42. PubMed ID: 6734255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ocular effects of xylazine in rabbits, cats, and monkeys.
    Burke JA; Potter DE
    J Ocul Pharmacol; 1986; 2(1):9-21. PubMed ID: 3503099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of ocular blood flow with dopamine antagonists on ocular-hypertensive rabbit eyes.
    Chiou GC; Chen YJ
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):481-4. PubMed ID: 1302433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity.
    Hong SJ; Wu KY; Chen IJ
    Curr Eye Res; 1998 Jul; 17(7):700-7. PubMed ID: 9678415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function.
    Potter DE; Shumate DJ
    J Ocul Pharmacol; 1987; 3(4):309-21. PubMed ID: 3503920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.